Randomized, Double-Blind, Placebo-Controlled Trial Demonstrates the Efficacy and Safety of Oral Aripiprazole for the Treatment of Tourette's Disorder in Children and Adolescents

Objectives: Aripiprazole modulates dopaminergic and serotonergic pathways that may play a role in the pathogenesis of Tourette's disorder (TD). This trial evaluated the efficacy and safety of oral aripiprazole in the suppression of tics in children and adolescents with TD. Methods: This phase 3...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Child Adolesc Psychopharmacol
Hauptverfasser: Sallee, Floyd, Kohegyi, Eva, Zhao, Joan, McQuade, Robert, Cox, Kevin, Sanchez, Raymond, van Beek, Alet, Nyilas, Margaretta, Carson, William, Kurlan, Roger
Format: Artigo
Sprache:Inglês
Veröffentlicht: Mary Ann Liebert, Inc. 2017
Schlagworte:
Original Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5689110/
https://ncbi.nlm.nih.gov/pubmed/28686474
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/cap.2016.0026
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge